Path AI / coverage

About

Ai is all the hype – and that’s not always a good thing. At SVM, we understand and value difference between “hype” and genuine thought leadership and insight that helps our clients stand out. This earned media opportunity had three of PathAI’s executives offering their perspectives on the centrality of pathology in the diagnosis, treatment and monitoring of patients in many disease areas, the how the adoption of digital pathology and AI can have lasting positive impact on patient outcomes, physician experience and the economy at large.